The fellow Luigi Naldini has been elected to the US National Academy of Medicine (NAM).
The prestigious recognition honors a pioneer of lentiviral gene therapy whose discoveries have led to approved treatments for rare diseases, including the first gene therapy brought to the U.S. market through a non-profit development pathway.